Topiramate (Topamax®) is an oral medication used to manage seizures and migraines by balancing electrical and nerve activity in the brain.
Topiramate
Topiramate
Topiramate is the active ingredient in the brand-name medication Topamax®, an anticonvulsant medication used to treat seizures and prevent migraines by stabilizing electrical activity in the brain and reducing abnormal brain cell firing.
The drug is FDA-approved to treat epilepsy, including partial onset and generalized tonic-clonic seizures, and for migraine prevention in adults and adolescents ages 12 and older.
Common side effects include dizziness, paresthesia, fatigue, weight loss, and trouble concentrating, and it carries a warning for increased risk of metabolic acidosis (a condition where too much acid builds up in the body) and kidney stones.
Topamax (topiramate) is indicated for:
Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older; adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older
Preventive treatment of migraine in patients 12 years of age and older
Anticonvulsant
Epilepsy: Most common (≥10% more frequent than placebo or low-dose Topamax) adverse reactions in adult and pediatric patients were:
Tingling
Anorexia
Weight loss
Speech disorders/Related speech problems
Fatigue
Dizziness
Sleepiness
Nervousness
Slowing down of physical and mental activities
Abnormal vision
Fever
Migraine: Most common (≥5% more frequent than placebo) adverse reactions in adult and pediatric patients were:
Tingling
Anorexia
Weight loss
Difficulty with memory
Taste perversion
Diarrhea
Loss of sensation
Nausea
Abdominal pain
Upper respiratory tract infection
The cost of topiramate varies depending on factors such as your insurance plan, which pharmacy you use, the dosage, and quantity. Without insurance, generic topiramate may cost around $70 and $165 for a month’s supply, although there are coupons and savings programs that may help you pay for the drug. Brand-name Topamax may cost between $475 and $540 for a month’s supply. Insurance plans may cover all or some of the cost of these medications.
Hers offers access to personalized Weight Loss Medication Kits. Kits may contain one of several combinations of medications that help support weight loss, such as a compounded version of topiramate**. These medication kits start at $69 per month with a monthly subscription plan paid in full. The cost includes a provider consultation, ongoing provider support, and access to the Hers app.
**Compounded medications are not approved or evaluated for safety, effectiveness, or quality by the FDA.
Drug interactions: contraceptives, lithium
Acute myopia and secondary angle closure glaucoma
Visual field defects
Oligohidrosis and hyperthermia
Metabolic acidosis
Suicidal behavior and ideation
Cognitive/Neuropsychiatric adverse reactions
Fetal toxicity
Withdrawal of AEDs
Decrease in bone mineral density
Negative effects on growth (height and weight)
Serious skin reactions
Hyperammonemia/Encephalopathy
Kidney stones
Hypothermia has been reported with and without hyperammonemia during topiramate treatment with concomitant valproic acid use
Topiramate is sometimes prescribed off-label for weight loss because it can decrease appetite and cause feelings of fullness after eating to last longer.
When combined with a healthy eating plan and regular physical activity, topiramate can lead to gradual weight loss. Everyone may respond differently to the medication, but research suggests you may see results within four months of starting the drug. But more significant weight loss is seen with longer treatment durations.
Topiramate is prescribed off-label for weight loss, so there is no official dose recommendation. However, research suggests that higher doses (192 to 384 mg) are more effective for weight loss than lower doses. But higher doses come with a higher risk of side effects.
Topiramate and phentermine are sometimes prescribed together, but they are two different types of drugs. Topiramate is an anti-seizure medication used to treat seizures and prevent migraines. It works by stabilizing electrical activity in the brain and reducing abnormal brain cell firing. It’s sometimes prescribed off-label for weight loss because it can help reduce appetite and cause feelings of fullness to last longer after you eat, but the reason it does so isn’t well understood.
*This information is from the label for brand name Topamax®. See the Full Prescribing Information for more complete information. Topiramate, the active ingredient in Topamax, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient topiramate.
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.
Ben-Menachem E, et al. (2003). Predictors of weight loss in adults with topiramate-treated epilepsy. https://pubmed.ncbi.nlm.nih.gov/12690085/
Bray GA, et al. (2003). A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. https://onlinelibrary.wiley.com/doi/10.1038/oby.2003.102
Epilepsy Foundation. (n.d.). Summary of anti-seizure medications. https://www.epilepsy.com/stories/summary-anti-seizure-medications
GoodRx. (2024). How much is topiramate without insurance? https://www.goodrx.com/topiramate/how-much-topiramate-costs-without-insurance
Kramer CK, et al. (2011). Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials. https://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2010.00846.x
National Library of Medicine. (2023). Phentermine and topiramate. https://medlineplus.gov/druginfo/meds/a612037.html
Rollo E, et al. (2023). Antiseizure medications for the prophylaxis of migraine during the anti-CGRP drugs era. https://pmc.ncbi.nlm.nih.gov/articles/PMC10514541/
Tonstad S, et al. (2005). Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension. https://pubmed.ncbi.nlm.nih.gov/16018851/